Russell J. Sanderson
Alpine Immune Sciences (United States)(US)Seagen (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, Bacterial Genetics and Biotechnology, DNA Repair Mechanisms
Most-Cited Works
- → Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity(2005)507 cited
- → Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates(2008)456 cited
- → Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate(2010)384 cited
- → Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates(2006)291 cited
- → Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: Protein mimicry of DNA(1995)283 cited
- → In vivoDrug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate(2005)279 cited
- → A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology(2013)243 cited
- → Processivity of Escherichia coli and Rat Liver Mitochondrial Uracil-DNA Glycosylase Is Affected by NaCl Concentration(1995)78 cited
- → Measurement of in Vivo Drug Load Distribution of Cysteine-Linked Antibody–Drug Conjugates Using Microscale Liquid Chromatography Mass Spectrometry(2014)70 cited
- → Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases(2023)54 cited